An in vivo pyelonephritis assay for screening therapeutic agents.
D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002228:Carbenicillin / Q000494:pharmacology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004231:Diuresis; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D007668:Kidney / Q000382:microbiology; D051379:Mice; D011512:Proteus Infections / Q000188:drug therapy; D011513:Proteus mirabilis / Q000302:isolation & purification; D011549:Pseudomonas / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy* / Q000382:microbiology; D012705:Serratia / Q000187:drug effects
D000667:Ampicillin; D002228:Carbenicillin